Pilot Trial of Mobile Technology for Adolescent Suicidality

Enrolling by invitation · Not applicable

Conditions studied: Suicidal Ideation

In brief

The primary objective of this study is to assess the efficacy of a digital intervention in reducing suicidal ideation in adolescents.

Key facts

Study ID

NCT06454136

Run by

Oui Therapeutics, Inc.

People needed

228

Starts

2025-10-23

Expected to finish

2027-03-01

Last updated by the study team

2025-11-05

Who can join

Age: 13 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients (of any sex), ages 13 to 17 years
• Patients who were recently hospitalized and have:
• attempted suicide or
• have documented SI and a history of attempted suicide, as verified by the Columbia-Suicide Severity Rating Scale (C-SSRS).
• Hospitalized is defined as admission to a medical or psychiatric service for further assessment and care including observation units, intensive care or other medical units and psychiatric units.
• Patient owns a smartphone capable of downloading and running apps
• Patient is willing and able to complete enrollment procedures
• Patient and Parent/Guardian are willing to assent/consent to medical record review for one year following randomization to collect suicide attempt data
• Patient and Parent/Guardian are able to understand the nature of the study and sign documentation of written informed assent (Patient) and consent (Parent/Guardian)
• Patient and Parent/Guardian understand written and spoken English
• Patient is willing to agree to release of information to their Parent/Guardian and providers when clinically indicated

You may not qualify if…

• Patients who are acutely intoxicated or in detoxification at the time of enrollment
• Patients who are currently enrolled in other treatment studies for the symptoms and behaviors targeted
• Patients who are incapable of understanding and following through with the study procedures (e.g., cognitive impairment)
• Patients with a psychiatric or medical condition or custody arrangement that, in the opinion of the PI, may compromise, interfere, limit, affect or reduce the patient's ability to provide informed consent, complete the study, or may adversely impact the safety of the patient or the integrity of the data. Examples of considerations include terminal illness where death would be anticipated before completing study procedures, active psychosis at the time of assent, severe or unstable medical condition.
• Patients whose discharge plans include transfer to inpatient care, as confirmed by the index hospitalization discharge summary/plan.

Where it is running

• Hartford HealthCare — Hartford, Connecticut, United States
• University of Cincinnati — Cincinnati, Ohio, United States
• Rhode Island/Bradley Hospital/Brown Health University — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.